Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature
ConclusionIn pediatric IBD, combining biological agents seems to be safe and beneficial in selected patients. The safety should be addressed in long-term follow-up studies.
Source: Pediatric Drugs - Category: Pediatrics Source Type: research
More News: Boys | Colectomy | Girls | Inflammatory Bowel Disease | Pediatrics | Psoriasis | Remicade | Skin | Stelara | Study | Ulcerative Colitis